Steatocystoma multiplex-natal teeth syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Nov 1992

Alkeran For Injection: FDA approved

For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Alkeran For Injection

Glaxo Wellcome Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Alkeran For Injection

(Melphalan)Orphan drug

Glaxo Wellcome Inc.

Approved Nov 1992FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Steatocystoma multiplex-natal teeth syndrome.
Search all trials →

Search clinical trials for Steatocystoma multiplex-natal teeth syndrome →

Recent News & Research

No recent news articles indexed yet for Steatocystoma multiplex-natal teeth syndrome.
Search PubMed for Steatocystoma multiplex-natal teeth syndrome →

Browse all Steatocystoma multiplex-natal teeth syndrome news →

Specialist Network

No specialists currently listed for Steatocystoma multiplex-natal teeth syndrome.

View all Steatocystoma multiplex-natal teeth syndrome specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰